中国药业Issue(23)：102-102,103,2.
利凡诺联合米非司酮用于瘢痕子宫中期妊娠引产34例
Clinical Study of Rivanol Combined with Mifepristone for Treating Induced Abortion in Scar Uterine Midtrimester Pregnancy in 34 Cases
高仁绩 1杨弟芳1
作者信息
- 1. 重庆市第九人民医院产科，重庆 400700
- 折叠
摘要
Abstract
Objective To investigate the effect of rivanol combined with mifepristone for treating induced abortion in scar uterine midtrimester pregnancy. Methods The clinical data of 66 patients with induced abortion in the scar uterine midtrimester pregnancy in our hospital from march 2011 to march 2014 were retrospectively analyzed. Among them, 32 cases were treated by rivanol(control group) and 34 cases were treated by rivanol combined with mifepristone(treatment group) . Then the effects and security were compared between the two groups. Results The initial time of uterine contraction, delivery time of fetus and placenta, bleeding volume and pla-cental residual rate in the treatment group were significantly lower than those in the control group( P < 0. 01); the laceration rate of soft birth canal and the success rate of induced abortion had no statistically significant difference between the two groups( P > 0. 05 ) . Conclusion The combination of rivanol with mifepristone has definite effect and good safety for induced abortion in scar uterine mistrimester pregnancy, and deserves to be clinically promoted.关键词
瘢痕子宫/中孕引产/利凡诺/米非司酮Key words
scar uterine/induced abortion in midtrimester pregnancy/rivanol/mifepristone分类
医药卫生引用本文复制引用
高仁绩,杨弟芳..利凡诺联合米非司酮用于瘢痕子宫中期妊娠引产34例[J].中国药业,2014,(23):102-102,103,2.
